ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,892, issued on Nov. 25, was assigned to Griffith University (Nathan, Australia).
"Immunogenic protein against gonococcal infection" was invented by Kate Seib (Nathan, Australia) and Evgeny Semchenko (Nathan, Australia).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates, inter alia, to an immunogenic fragment of a Neisserial Heparin Binding Antigen (NHBA) protein of Neisseria gonorrhoeae (SEQ ID NO: 1) for the prevention and treatment of Neisseria gonorrhoeae or gonococcal- or meningococcal-associated diseases and conditions. In some embodiments, the immunogenic fragment corresponds to a C-terminal fragment of the protein (SEQ ID NO...